They found a significantly lower level of activated AKT, notably phosphorylated on serine 473 (pAKTSer473) in human GBM expressing low levels of Tau RNA (MAPT gene, with p-value = 0.0078). The gene discussed is MAPT; the disease is glioblastoma.